de Bittencourt Pasquali, Matheus Augusto <br/><br/>
Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells.  [electronic resource] 

 -  Cellular signalling  Apr 2013 
 - 939-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3913 
<br/><br/><label>Standard No.: </label>10.1016/j.cellsig.2013.01.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antioxidants--pharmacology<br/>Cell Line, Tumor<br/>Down-Regulation--drug effects<br/>Humans<br/>Imidazoles--pharmacology<br/>Lung Neoplasms--metabolism<br/>Mitogen-Activated Protein Kinase 11--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinase 14--antagonists & inhibitors<br/>NF-kappa B--antagonists & inhibitors<br/>Oxidation-Reduction<br/>Peptides--pharmacology<br/>Phosphorylation--drug effects<br/>Pyridines--pharmacology<br/>RNA Interference<br/>RNA, Small Interfering--metabolism<br/>Receptor for Advanced Glycation End Products<br/>Receptors, Immunologic--metabolism<br/>Signal Transduction--drug effects<br/>Transcription Factor RelA--metabolism<br/>Vitamin A--pharmacology<br/>alpha-Tocopherol--pharmacology<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors